MassBio CEO & President Kendalle Burlin O’Connell originally posted this update to LinkedIn: MassBio Back on the Hill: Our ...
Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases ...
MassBio is partnering with the ElevateBio team on November 2 to host 2026 R&D Reimagined – Techbio Solutions, the second in a ...
Statement from MassBio CEO & President Kendalle Burlin O’Connell on today’s release of proposed COINS Act rules: “Today, the ...
New, free book offers simple but empowering information on how to care for people with cancer while also caring for yourself.
ODC Life Sciences is a specialized clinical research partner in Latin America, combining global clinical development ...
MassBio is partnering with the Arthur D. Little team on November 2 to host 2026 R&D Reimagined – Techbio Solutions, the ...
Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), and Acesion Pharma, a Copenhagen-based biotech company developing treatments for cardiac ...
Join us at the 2026 Big Tree, Mansfield Bio-Incubator’s partner, ACORN Summit, presented in partnership with Boston University Questrom School of Business, on October 30, bringing together 200+ ...
We are pleased to share with you the 2026 MassBio Industry Snapshot. This annual report tracks the Massachusetts biopharma industry’s changes, including employment, industry investment, drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results